<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="833">
  <stage>Registered</stage>
  <submitdate>13/10/2005</submitdate>
  <approvaldate>28/08/2006</approvaldate>
  <actrnumber>ACTRN12606000376549</actrnumber>
  <trial_identification>
    <studytitle>An evaluation of the clinical outcomes of the subvastus versus the medial parapatella approach to total knee replacement</studytitle>
    <scientifictitle>An evaluation of the clinical outcomes (American Knee Society Score, Knee Range of Motion, Quadriceps Function, Functional Mobility, Pain, Patella Vascularity) of the subvastus versus the medial parapatella approach to total knee replacement</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>1111111111</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Total Knee Replacement</healthcondition>
    <conditioncode>
      <conditioncode1>Musculoskeletal</conditioncode1>
      <conditioncode2>Other surgery</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Medial Parapatella approach to Total Knee Replacement involves dissection through the quadriceps. The Subvastus approach does not. 
Assessments will be performed at PreOperative Period, Days 1,2,3; 6 Weeks, 6 months, 12 months and 18 months post operatively</interventions>
    <comparator>No comparator.</comparator>
    <control>Active</control>
    <interventioncode>Treatment: surgery</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>1. American Knee Society Score</outcome>
      <timepoint>All primary outcome measures in this study will be measured at PreOperative Period, Day 1,2,3; 6 Weeks, 6 months, 12 months and 18 months post operatively.</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>2. Quadriceps Function</outcome>
      <timepoint>All primary outcome measures in this study will be measured at PreOperative Period, Day 1,2,3; 6 Weeks, 6 months, 12 months and 18 months post operatively.</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>3. Knee Range of motion</outcome>
      <timepoint>All primary outcome measures in this study will be measured at PreOperative Period, Day 1,2,3; 6 Weeks, 6 months, 12 months and 18 months post operatively.</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>4. Pain</outcome>
      <timepoint>All primary outcome measures in this study will be measured at PreOperative Period, Day 1,2,3; 6 Weeks, 6 months, 12 months and 18 months post operatively.</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>5. Functional Mobility</outcome>
      <timepoint>All primary outcome measures in this study will be measured at PreOperative Period, Day 1,2,3; 6 Weeks, 6 months, 12 months and 18 months post operatively.</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>6. Timed Up and Go Test</outcome>
      <timepoint>All primary outcome measures in this study will be measured at PreOperative Period, Day 1,2,3; 6 Weeks, 6 months, 12 months and 18 months post operatively.</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>7. Knee girth</outcome>
      <timepoint>All primary outcome measures in this study will be measured at PreOperative Period, Day 1,2,3; 6 Weeks, 6 months, 12 months and 18 months post operatively.</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Intra-operative data being collected includes knee range of motion, knee stability, incision length, torniquet time, operation time (knife to skin - wound closure).</outcome>
      <timepoint>All primary outcome measures in this study will be measured at PreOperative Period, Day 1,2,3; 6 Weeks, 6 months, 12 months and 18 months post operatively.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Economic benefits</outcome>
      <timepoint>Assessed upon study completion.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Patella vascularity</outcome>
      <timepoint>Assessed at 18 months post operatively.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Adult participants. The expected age range of subjects undergoing total knee replacement surgery is between 50 and 65 years. Patients undergoing primary unilateral total knee replacement. Diagnosis of osteoarthritis. Healthy and no comorbidities that would prevent participating in the required rehabilitation programme. Normal mentation with the ability to accurately follow commands. Ability to attend supervised outpatient physiotherapy rehabilitation session(s) after being discharged from hospital. Ability to participate voluntarily and provide signed informed consent.</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>Not stated</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Persons with concomitant medical conditions such as malignant tumours or severe Chronic Obstructive Pulmonary Disease that would prevent participation in the required rehabilitation programme. Lateral surgical approach required. Inability to follow commands. Persons not able to mobilise in a bipedal manner with or without a walking aid. Conditions preventing full weight bearing post-operatively. The inability to provide signed informed consent. Revision TKR or any previous major arthrotomy or previous High Tibial Osteotomy on the knee to be operated onLess than 70 degrees of flexion. Persons undergoing bi-lateral total knee replacements. Persons identified as being unlikely to follow Queensland Health's TKR Clinical Pathway (e.g. requiring admission to the rehabilitation unit preoperatively) Greater than 15 degree FFD (Fixed flexion deformity).</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>1. sealed opaque envelopes. 3. central randomisation</concealment>
    <sequence>Permuted block randomisation.  Ratio 1:1</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures>Physiotherapist blinded to intervention collects all measures at each assessment point.  Participants blinded to intervention. Surgeon who is unblided to the intervention collects Intraoperative data.</designfeatures>
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 1</phase>
    <anticipatedstartdate>14/07/2006</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>64</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Government body</primarysponsortype>
    <primarysponsorname>Queensland Health</primarysponsorname>
    <primarysponsoraddress>Queensland Health - QEII Jubile Hospital
Kessels Rd
Nathan Brisbane QLD</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Government body</fundingtype>
      <fundingname>Queensland Health</fundingname>
      <fundingaddress>Queensland Health</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>University</sponsortype>
      <sponsorname>University of Queensland, Brisbane</sponsorname>
      <sponsoraddress>St Lucia, Brisbane</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Study Hypothesis:  We hypothesise that participants receiving the subvastus approach will enjoy better medium term funtional outcomes than those receiving the medial parapatell approach.
Physiotherapists are blinded to the intervention and will collect all outcome measures at each assessment point.  Participants are blinded to the intervention.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Princess Alexandra Hospital HREC-QEII Jubilee Hospital</ethicname>
      <ethicaddress>St Lucia Brisbane</ethicaddress>
      <ethicapprovaldate>31/01/2006</ethicapprovaldate>
      <hrec>2005/191</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>University of QLD Medical Research Ethics Committee</ethicname>
      <ethicaddress />
      <ethicapprovaldate>8/03/2006</ethicapprovaldate>
      <hrec>2006000154</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Mr Michael Bourke</name>
      <address>Queen Elizabeth II Jubilee Hospital
Private Bag 2
Acacia Ridge
Brisbane QLD 4110</address>
      <phone>+61 7 32756173</phone>
      <fax>+61 7 3275 6579</fax>
      <email>michael_bourke@health.qld.gov.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Mr Michael Bourke</name>
      <address>Queen Elizabeth II Jubilee Hospital
Private Bag 2
Acacia Ridge
Brisbane QLD 4110</address>
      <phone>+61 7 32756173</phone>
      <fax>+61 7 3275 6579</fax>
      <email>michael.bourke@uqconnect.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>